DNM1L and Cerebral ischemia: All of these findings imply the protective and beneficial effects of the Drp1 inhibitor on the attenuation of mitochondrial fragmentation, mitochondrial dysfunction, and consequently a decrease in apoptotic cell death, resulting in the reduction of infarct volume and neurological deficits following cerebral ischemia/reperfusion injury.